2 unchanged sentences
Neogen Common Stock is traded on the NASDAQ Global Select Market under the symbol NEOG.
−Removed: As of June 30, 2021, there were approximately 221 stockholders of record of Common Stock and management believes there are a total of approximately 10,000 beneficial holders.
−Removed: Neogen has never paid cash dividends on its Common Stock.
+Added: As of June 30, 2022, there were 215 stockholders of record of our common stock.
+Added: The actual number of holders is greater than this number of holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees.
+Added: Neogen has never paid cash dividends on its Common Stock and does not expect to pay dividends in the foreseeable future.
+Added: Securities Authorized for Issuance under Equity Compensation Plan
+Added: Equity Compensation Plan Information
+Added: (shares in thousands)
+Added: Number of shares to be issued upon
+Added: exercise of outstanding options and
+Added: Weighted average
+Added: outstanding options
+Added: Number of securities remaining available for future
+Added: issuance under equity compensation plans (excluding
+Added: securities reflected in first column) (2)
+Added: Equity compensation plans approved by shareholders
+Added: Equity compensation plans not approved by shareholders
+Added: Outstanding options and RSUs as of May 31, 2022.
+Added: Reflects shares available for future issuance as May 31, 2022 under our 2018 Omnibus Incentive Plan dated August 28, 2018 and approved by shareholders on October 4, 2018.
+Added: For additional information, see Note 5, Equity Compensation Plans, in the consolidated financial statements.
The graph below matches Neogen Corporation’s cumulative 5-Year
4 unchanged sentences
NASDAQ Medical Equipment
+Added: S&P Life Sciences Tools & Services
The stock price performance included in this graph is not necessarily indicative of future stock price performance.
−Removed: SELECTED FINANCIAL DATA
−Removed: The following tables set forth selected consolidated financial data of Neogen for the year ended May 31, 2021, and each of the four preceding fiscal years.
−Removed: The selected consolidated financial data presented below have been derived from our consolidated financial statements.
−Removed: This financial data should be read in conjunction with the consolidated financial statements, related notes and other financial information appearing elsewhere in this Form 10-K.
−Removed: Year Ended May 31
−Removed: (in thousands, except per share data)
−Removed: Income Statement Data:
−Removed: Food Safety Revenues
−Removed: Animal Safety Revenues
−Removed: Total Revenues
−Removed: Total Cost of Revenues
−Removed: Sales and Marketing
−Removed: General and Administrative
−Removed: Research and Development
−Removed: Operating Income
−Removed: Income Before Income Taxes
−Removed: Provision for Income Taxes
−Removed: Net (Income) Loss Attributable to Non-controlling
−Removed: Net Income Attributable to Neogen
−Removed: Net Income per Share (basic) (1)
−Removed: Net Income per Share (diluted) (1)
−Removed: Weighted Average Shares Outstanding (diluted) (1)
−Removed: Year Ended May 31
−Removed: Balance Sheet Data:
−Removed: Cash and Cash Equivalents and Marketable Securities
−Removed: Working Capital (2)
−Removed: Long-Term Debt
−Removed: On December 29, 2017, the Company effected a 4-for-3
−Removed: stock split whereby shareholders of record on December 18, 2017 received a dividend of one additional share of stock for each three shares held.
−Removed: On June 4, 2021, the Company effected a 2-for-1
−Removed: stock split whereby shareholders on record as of May 26, 2021 received a dividend of one additional share of common stock for each share held.
−Removed: All share and per share amounts in this Form 10-K
−Removed: have been adjusted to reflect both stock splits as if they had taken place at the beginning of the periods presented.
−Removed: Defined as current assets less current liabilities.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.